Eczema Management in Adolescents
Introduction to Eczema Treatment
- The American Academy of Dermatology recommends liberal daily emollient application combined with mild-to-moderate potency topical corticosteroids applied to affected areas during flare-ups 1, 2
Daily Maintenance Therapy
- Apply emollients liberally and frequently throughout the day to maintain skin hydration and improve barrier function 1, 2
- Apply emollients immediately after bathing when skin is still slightly damp to maximize moisture retention 1, 2
- Replace regular soaps with soap-free cleansers or dispersable cream substitutes to prevent removal of natural skin lipids 1, 2
Bathing Practices
- Use soap-free shower gels and/or bath oils for cleansing 3, 4
- Avoid alcohol-containing lotions or gels, which can worsen dry skin 3, 5
Treatment of Active Flare-Ups
- Start with mild-to-moderate potency topical corticosteroids applied once daily to affected areas 1, 2
- For facial involvement, use only mild-potency preparations due to increased risk of skin thinning 2
Duration and Monitoring
- Apply topical corticosteroids for short periods until the flare resolves 1, 2
- Reassess after 2 weeks; if no improvement or worsening occurs, consider increasing potency or referring to dermatology 3, 4, 5
Managing Pruritus
- For significant itching during flares, consider short-term use of sedating antihistamines primarily for their sedative properties to help with sleep 1
- Urea- or polidocanol-containing lotions can help soothe itching 3, 5
Monitoring for Secondary Complications
- Watch for signs of secondary bacterial infection: crusting, weeping, or discharge 1, 2
- If bacterial infection is suspected, treat with appropriate antibiotics 1
- Monitor for viral infections, particularly eczema herpeticum, which requires prompt treatment 1, 2
Safety Considerations for Topical Corticosteroids
- Adolescents have lower risk of systemic absorption compared to infants due to lower body surface area-to-volume ratio 1
When to Refer to Dermatology
- Failure to respond to first-line treatment after 6 weeks 1, 2
- Diagnostic uncertainty 1, 2
- Need for second-line treatments or severe disease affecting quality of life despite appropriate first-line therapy 1, 2